Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Otis W. Brawley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Herve Hoppenot - $19.77M in INCY purchases and sales in the last 12 months
- Pablo J. Cagnoni - $14.10M in INCY purchases and sales in the last 12 months
- ARCH Venture Partners IX, LLC - $12.50M in LYEL purchases and sales in the last 12 months
- ARCH Venture Fund XIII, L.P. - $12.50M in LYEL purchases and sales in the last 12 months
- Steven H. Stein - $6.27M in INCY purchases and sales in the last 12 months
- Patrick A. Mayes - $6.01M in INCY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Otis W. Brawley?
Otis W. Brawley is a corporate insider of Lyell Immunopharma, Inc. (LYEL). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Otis W. Brawley last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 8 filings going back to 2025.
Has Otis W. Brawley been buying or selling stock?
Recorded transactions: 1 open-market purchase ($20K) and 0 open-market sales across all tracked filings.
